Schonfeld Strategic Advisors LLC 13D and 13G filings for Fate Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-14 4:30 pm Sale | 2025-06-30 | 13G | Fate Therapeutics, Inc. FATE | Schonfeld Strategic Advisors LLC | 937,521 0.820% | -6,856,992 (-87.97%) | Filing |
| 2025-05-15 4:30 pm Purchase | 2025-03-31 | 13G | Fate Therapeutics, Inc. FATE | Schonfeld Strategic Advisors LLC | 7,794,513 6.800% | 7,794,513 (New Position) | Filing |